mynth
← DATABASE
02/2026

DSM-FIRMENICH ANH (ANIMAL NUTRITION & HEALTH) acquired by CVC

SWITZERLAND Chemicals & Materials / Specialty Chemicals / Nutrition EV 1b - 4b EUR

Context

DSM-Firmenich has agreed to sell a majority interest in its Animal Nutrition and Health (ANH) business to CVC Capital Partners. Under the terms of the agreement, DSM-Firmenich will retain a 20% minority stake to benefit from future upside. The transaction structure involves a combination of cash proceeds (~EUR600 million) and the transfer of debt/liabilities (~EUR500 million) to the new standalone entity. Additionally, the deal includes an earn-out component based on future performance. Post-closing, the business will be operationally split into two separate entities: "Solutions Company" and "Essential Products Company," both headquartered in Switzerland. A long-term supply agreement has been established to ensure the ongoing provision of vitamins between the parent and the divested entities.

DSM-FIRMENICH ANH (ANIMAL NUTRITION & HEALTH), which reported an EBITDA margin of in 2025, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Industry & Manufacturing sector (11.7x).

-> Deep-dive in Industry & Manufacturing market trends

Target

The Animal Nutrition & Health (ANH) division of DSM-Firmenich is one of the world's largest suppliers of vitamins, carotenoids, eubiotics, and feed enzymes for the livestock industry. Headquartered in Kaiseraugst (Switzerland), the division employs approximately 8,000 people.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2025
2024

Similar deals in Chemicals & Materials

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
04/2026LIFCOMETALLTECHITALYConstruction Materials
03/2026ProAmpacTC Transcontinental PackagingUNITED STATESPlastic Packaging
02/2026STRATUS PACKAGINGFREPPEL IMPRIMEURFRANCELabels & Adhesives
02/2026ONE EQUITY PARTNERSGIOVANNI BOZZETTOITALYSpecialty Chemicals
02/2026MEARTHANE PRODUCTS CORPORATIONAXILLON AEROSPACE - POLYURETHANEUNITED STATESPlastics
02/2026SAGARDESSENCES & PARFUMSFRANCEFlavors & Fragrances
02/2026HENKELSTAHLNETHERLANDSPaints & Coatings
01/2026SNF GROUPSYENSQO OIL & GAS BUSINESS UNITBELGIUMSpecialty Chemicals
01/2026ARKEA CAPITALGROUPE BARTOLACFRANCEPaints & Coatings
01/2026IRD INVEST / MANAGEMENT & PRIVATE INVESTORSDECADEFRANCEPackaging & Containers

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 2.5b - 5b EUR

EBITDA range: 250M - 500M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DSM-FIRMENICH ANH (ANIMAL NUTRITION & HEALTH) by CVC are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: cvc